MicroRNA-146b-3p regulates the dysfunction of vascular smooth muscle cells via repressing phosphoinositide-3 kinase catalytic subunit gamma

References

• Jaminon A, Reesink K, Kroon A, et al. The role of vascular smooth muscle cells in arterial remodeling: focus on calcification-related processes. Int J Mol Sci. 2019;20(22):5694.
   PubMed Web of Science ®Google Scholar
• Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118(4):692–702.
   PubMed Web of Science ®Google Scholar
• Basatemur GL, Jørgensen HF, Clarke MCH, et al. Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol. 2019;16:727–744.
   PubMed Web of Science ®Google Scholar
• Miano JM, Fisher EA, Majesky MW. Fate and state of vascular smooth muscle cells in Atherosclerosis. Circulation. 2021;143(21):2110–2116.
   PubMed Web of Science ®Google Scholar
• Cucina A, Borrelli V, Randone B, et al. Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells. J Surg Res. 2003;109(1):16–23.
   PubMed Web of Science ®Google Scholar
• Wang D, Atanasov AG. The microRNAs regulating vascular smooth muscle cell proliferation: a minireview. Int J Mol Sci. 2019;20(2):324.
   PubMed Web of Science ®Google Scholar
• Tang Y, Yu S, Liu Y, et al. MicroRNA-124 controls human vascular smooth muscle cell phenotypic switch via Sp1. Am J Physiol Heart Circ Physiol. 2017;313(3):H641–H649.
   PubMed Web of Science ®Google Scholar
• Yao S, Xu J, Zhao K, et al. Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways. Cell Death Dis. 2018;9(11):1055.
   PubMedGoogle Scholar
• Huang W, Guo L, Zhao M, et al. The Inhibition on MDFIC and PI3K/AKT pathway caused by miR-146b-3p triggers suppression of myoblast proliferation and differentiation and promotion of apoptosis. Cells. 2019;8(7):656.
   PubMed Web of Science ®Google Scholar
• Kratz CP, Emerling BM, Bonifas J, et al. Genomic structure of the PIK3CG gene on chromosome band 7q22 and evaluation as a candidate myeloid tumor suppressor. Blood. 2002;99(1):372–374.
   PubMed Web of Science ®Google Scholar
• Bis JC, White CC, Franceschini N, et al. Sequencing of 2 subclinical atherosclerosis candidate regions in 3669 individuals: cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium targeted sequencing study. Circ Cardiovasc Genet. 2014;7(3):359–364.
   PubMedGoogle Scholar
• Yu Q, Li W, Jin R, et al. PI3Kγ (Phosphoinositide 3-Kinase γ) regulates vascular smooth muscle cell phenotypic modulation and neointimal formation through CREB (Cyclic AMP-Response Element Binding Protein)/YAP (Yes-Associated Protein) signaling. Arterioscler Thromb Vasc Biol. 2019;39(3):e91–e105.
   PubMed Web of Science ®Google Scholar
• Nazari-Jahantigh M, Wei Y, Noels H, et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest. 2012;122(11):4190–4202.
   PubMed Web of Science ®Google Scholar
• Döring Y, Manthey HD, Drechsler M, et al. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation. 2012;1(13):1673–1683.
   Google Scholar
• Skogsberg J, Lundström J, Kovacs A, et al. Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes. PLoS Genet. 2008;4(3):e1000036.
   PubMed Web of Science ®Google Scholar
• Yang F, Chen Q, He S, et al. miR-22 Is a novel mediator of vascular smooth muscle cell phenotypic modulation and neointima formation. Circulation. 2018;137(17):1824–1841.
   Google Scholar
• Abulizi R, Li B, Zhang CG. Circ_0071662, a novel tumor biomarker, suppresses bladder cancer cell proliferation and invasion by sponging miR-146b-3p. Oncol Res. 2019. DOI:10.3727/096504019X15740729375088
   PubMedGoogle Scholar
• Yu C, Zhang L, Luo D, et al. MicroRNA-146b-3p promotes cell metastasis by directly targeting NF2 in human papillary thyroid cancer. Thyroid. 2018;28(12):1627–1641.
   Google Scholar
• Su Z, Wu F. Inflammatory factors induce thrombosis through the miR-146b-3p/p38MAPK/COX-2 pathway. Biomed Res Int. 2020;2020:8718321.
   PubMed Web of Science ®Google Scholar
• Pridham KJ, Varghese RT, Sheng Z. The role of class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase catalytic subunits in glioblastoma. Front Oncol. 2017;7:312.
   PubMed Web of Science ®Google Scholar
• Kächele M, Hennige AM, Machann J, et al. Variation in the Phosphoinositide 3-Kinase Gamma gene affects plasma HDL-cholesterol without modification of metabolic or inflammatory markers. PLoS One. 2015;10(12):e0144494.
   PubMed Web of Science ®Google Scholar
• Fougerat A, Gayral S, Gourdy P, et al. Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes. Circulation. 2008;117(10):1310–1317.
   PubMed Web of Science ®Google Scholar
• Zotes TM, Arias CF, Fuster JJ, et al. PI3K p110γ deletion attenuates murine atherosclerosis by reducing macrophage proliferation but not polarization or apoptosis in lesions. PLoS One. 2013;8(8):e72674.
   PubMed Web of Science ®Google Scholar
• Smirnova NF, Gayral S, Pedros C, et al. Targeting PI3Kγ activity decreases vascular trauma-induced intimal hyperplasia through modulation of the Th1 response. J Exp Med. 2014;211(9):1779–1792.
   Google Scholar
• Zhang M, Li F, Wang X, et al. MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K/Akt/mTOR pathway. Histochem Cell Biol. 2020;153(5):357–366.
   PubMed Web of Science ®Google Scholar
• Lupieri A, Smirnova NF, Solinhac R, et al. Smooth muscle cells-derived CXCL10 prevents endothelial healing through PI3Kγ-dependent T cells response. Cardiovasc Res. 2020;116(2):438–449.
   PubMed Web of Science ®Google Scholar